The Symposium is aimed at drug safety representatives from the pharmaceutical industry and academic and quality research organisations who wish to understand how to avoid common deficiencies in inspections by learning from the experiences of others; to gain a greater understanding of new and existing pharmacovigilance requirements, and to understand the MHRA expectations in order to improve their organisations’ compliance with pharmacovigilance requirements.
Held on 26 March 2013 in London, the questions and answers from the event are now available below.
Q&As from the GPvP Symposium 2013